Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?

Overview Forecast RevenueFinancials Chart Transcripts

Neurocrine Biosciences Ownership Summary

Neurocrine Biosciences is owned by 23.24% institutional investors, 1.03% insiders, and 75.73% retail investors. Blackrock is the largest institutional shareholder, holding 14.22% of NBIX shares. Dodge & Cox Stock I is the top mutual fund, with 4.01% of its assets in Neurocrine Biosciences shares.

NBIX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Neurocrine Biosciences	23.24%	1.03%	75.73%
Sector	Healthcare Stocks	232.51%	10.72%	-143.23%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.82%	11.62%	67.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	14.19M	14.22%	$1.95B
Blackrock funding, inc. /de	12.83M	12.90%	$1.82B
Vanguard group	9.70M	9.76%	$1.38B
Dodge & cox	5.56M	5.61%	$780.04M
Jpmorgan chase	5.20M	5.23%	$737.57M
State street	4.35M	4.39%	$610.16M
Price t rowe associates inc /md/	2.87M	2.90%	$402.43M
Renaissance	2.24M	2.25%	$317.53M
Geode capital management	2.06M	2.07%	$291.34M
Aqr capital management	1.90M	1.88%	$258.93M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sarissa capital management lp	303.15K	23.59%	$42.56M
Boone capital management	166.41K	7.66%	$23.36M
Bellevue group	1.76M	5.14%	$247.50M
Eagle health investments lp	162.80K	5.07%	$23.09M
Healthinvest partners ab	94.80K	4.29%	$13.44M
Braidwell lp	880.28K	3.67%	$123.57M
Birchview capital, lp	28.69K	3.04%	$4.03M
Avidity partners management lp	220.40K	2.95%	$30.08M
Iron triangle partners lp	131.39K	2.62%	$18.44M
Deerfield management company, l.p. (series c)	1.18M	2.54%	$166.26M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	1.15M	0.02%	1.15M
Ubs group	983.53K	0.02%	618.96K
Jpmorgan chase	5.20M	0.05%	470.20K
Blackrock	14.19M	0.04%	429.74K
Two sigma investments, lp	347.56K	0.07%	347.56K

Top Sellers

Holder	Shares	% Assets	Change
Dsm capital partners	-	-	-932.60K
Point72 asset management	-	-	-837.43K
Morgan stanley	1.21M	0.01%	-617.56K
Jupiter asset management	-	-	-582.79K
Jennison associates	-	-	-519.95K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.15M	0.02%	1.15M	$162.66M
Axa investment managers	323.90K	0.12%	323.90K	$45.47M
Rakuten investment management	128.74K	0.03%	128.74K	$8.62M
Cookson peirce	107.27K	0.63%	107.27K	$15.21M
Worldquant millennium advisors	62.02K	0.04%	62.02K	$8.71M

Sold Out

Holder	Change
New millennium group	-1.00
Wealthtrak capital management	-1.00
Crewe advisors	-2.00
Rosenberg matthew hamilton	-4.00
Ameritas advisory services	-5.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	286	-56.60%	23,096,413	-76.21%	23	0.24%	161	-53.47%	78	-63.72%
Sep 30, 2025	313	-46.40%	27,003,435	-70.64%	27	0.32%	165	-45.54%	95	-55.40%
Jun 30, 2025	588	0.17%	97,956,548	4.05%	98	1.11%	302	20.32%	215	-15.02%
Mar 31, 2025	585	-3.94%	94,105,380	-0.29%	94	1.07%	246	-24.31%	257	22.38%
Dec 31, 2024	555	-5.77%	87,755,246	-5.34%	86	1.03%	288	-3.36%	196	-2.97%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Dodge & Cox Stock I	3.96M	4.01%	-
iShares Core S&P Mid-Cap ETF	3.22M	3.25%	-
Vanguard US Total Market Shares ETF	3.20M	3.21%	2.53K
Vanguard Total Stock Mkt Idx Inv	3.12M	3.14%	-71.50K
Vanguard Small Cap Index	2.40M	2.42%	-15.57K
BB Biotech AG Ord	1.82M	1.80%	-40.00K
Vanguard Small Cap Growth Index Inv	1.35M	1.36%	-3.15K
Vanguard Windsor Investor Shares	1.13M	1.14%	-2.80K
JPM US Mid Cap Growth-Composite	1.12M	1.13%	543.28K
JPMorgan Mid Cap Growth I	1.11M	1.12%	-3.53K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 16, 2026	Gano Kyle	Chief Executive Officer	Sell	$4.59M
Jan 16, 2026	Gano Kyle	Chief Executive Officer	Sell	$240.48K
Dec 16, 2025	Norwalk Leslie V	-	Sell	$184.56K
Dec 15, 2025	Norwalk Leslie V	-	Sell	$761.14K
Dec 08, 2025	Lippoldt Darin	Chief Legal Officer	Sell	$698.62K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	8
2025 Q3	-	4
2025 Q2	-	2
2025 Q1	-	45
2024 Q4	-	4

NBIX Ownership FAQ

Who Owns Neurocrine Biosciences?

Neurocrine Biosciences shareholders are primarily institutional investors at 23.24%, followed by 1.03% insiders and 75.73% retail investors. The average institutional ownership in Neurocrine Biosciences's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Neurocrine Biosciences exceeds.

Who owns the most shares of Neurocrine Biosciences?

Neurocrine Biosciences’s largest shareholders are Blackrock (14.19M shares, 14.22%), Blackrock funding, inc. /de (12.83M shares, 12.90%), and Vanguard group (9.7M shares, 9.76%). Together, they hold 36.87% of Neurocrine Biosciences’s total shares outstanding.

Does Blackrock own Neurocrine Biosciences?

Yes, BlackRock owns 14.22% of Neurocrine Biosciences, totaling 14.19M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.95B$. In the last quarter, BlackRock increased its holdings by 429.74K shares, a 3.12% change.

Who is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested, with 23.59% of its assets in 303.15K Neurocrine Biosciences shares, valued at 42.56M$.

Who is the top mutual fund holder of Neurocrine Biosciences shares?

Dodge & Cox Stock I is the top mutual fund holder of Neurocrine Biosciences shares, with 4.01% of its total shares outstanding invested in 3.96M Neurocrine Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools